Interview in "BioTechnologie Kursbuch No. 37"

Hamburg, Germany (June 20, 2024) - Feature in BioTechnologie Kursbuch No. 37

“As cancer is as individual as people themselves, individual approaches to therapy are just as useful. Everything that is currently being developed has its potential justification - the decisive factor will be to use it at the right time based on individual variables and, if necessary, in appropriate combinations.” says Hartmut Juhl, when being asked about the diverse approaches in fighting cancer.

We are happy to share the “Kursbuch Biotechnologie” article (german), based on an interview with our Founder and CEO Prof. Dr. Hartmut Juhl.

Read the article

For the full edition of the Biotechnology Kursbuch, please view the online version available here.